GT Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GT Biopharma and other ETFs, options, and stocks.About GTBP
GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of the immuno-oncology therapeutic products based proprietary TriKE NK cell engager platform. The TriKE platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells).
CEOMichael Breen
CEOMichael Breen
Employees1
Employees1
HeadquartersSan Francisco, California
HeadquartersSan Francisco, California
Founded1965
Founded1965
Employees1
Employees1
GTBP Key Statistics
Market cap9.75M
Market cap9.75M
Price-Earnings ratio-0.54
Price-Earnings ratio-0.54
Dividend yield—
Dividend yield—
Average volume86.82K
Average volume86.82K
High today$3.49
High today$3.49
Low today$3.05
Low today$3.05
Open price$3.40
Open price$3.40
Volume85.55K
Volume85.55K
52 Week high$4.10
52 Week high$4.10
52 Week low$1.72
52 Week low$1.72
People also own
Based on the portfolios of people who own GTBP. This list is generated using Robinhood data, and it’s not a recommendation.